Yvonne Nilsson
Overview
Explore the profile of Yvonne Nilsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Georgievska B, Sandin J, Doherty J, Mortberg A, Neelissen J, Andersson A, et al.
J Neurochem
. 2013 Feb;
125(3):446-56.
PMID: 23410232
Abnormal tau phosphorylation resulting in detachment of tau from microtubules and aggregation are critical events in neuronal dysfunction, degeneration, and neurofibrillary pathology seen in Alzheimer's disease. Glycogen synthase kinase-3β (GSK3β)...
2.
Berg S, Bergh M, Hellberg S, Hogdin K, Lo-Alfredsson Y, Soderman P, et al.
J Med Chem
. 2012 Apr;
55(21):9107-19.
PMID: 22489897
Glycogen synthase kinase-3β, also called tau phosphorylating kinase, is a proline-directed serine/threonine kinase which was originally identified due to its role in glycogen metabolism. Active forms of GSK3β localize to...
3.
Marsell R, Sisask G, Nilsson Y, Sundgren-Andersson A, Andersson U, Larsson S, et al.
Bone
. 2011 Dec;
50(3):619-27.
PMID: 22142634
Glycogen synthase kinase 3β (GSK-3β) actions are central in the canonical Wnt pathway, important in many biological processes and a potential drug target for treating several diseases. It is appreciated...
4.
Bhat R, Xue Y, Berg S, Hellberg S, Ormo M, Nilsson Y, et al.
J Biol Chem
. 2003 Aug;
278(46):45937-45.
PMID: 12928438
Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer's disease. We report the characterization of a GSK3 inhibitor,...